[en] The present invention provides a method of treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphate. L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.
Disciplines :
Immunology & infectious disease
Inventor :
tasken, kjetil
MOUTSCHEN, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Maladies infectieuses et médecine interne générale
Rahmouni, Souad ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Aandahl, Einar MArtin
Aukurst, Pal
Froland, Stig
Johansson, Christian
Hansson, Vidar
Klaveness, Jo
Language :
English
Title (54) :
Use of COX-2 inhibitors for preventing immunodeficiency
